臨床試驗

Hypertension Treatment in Nigeria: Hypertension Diabetes Integration Study- Formative Aim 3

NCT：NCT07589387 · NOT_YET_RECRUITING

NCT IDNCT07589387

狀態NOT_YET_RECRUITING

開始日期2026-05-01

完成時間2030-01-31

SponsorWashington University School of Medicine (OTHER)

First posted2026-05-15

Last updated2026-05-15

簡要摘要

The purpose of the second phase of the Hypertension Treatment in Nigeria (HTN 2.0) Program is to build upon the success of the first phase of the HTN Program (2020-2023), which implemented the WHO HEARTS package across 60 primary healthcare centers (PHCs) in the Federal Capital Territory (FCT). This program demonstrated significant improvements in hypertension treatment and control. The focus of aim 3 will be evaluating diabetes management through the implementation of the HEARTS-D bundle in 10 PHCs across the FCT that previously participated in the initial HTN Program.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。